Seasonal Influenza and Pneumococcal Vaccination in the Elderly

The elderly population and individuals with chronic diseases are at high risk for influenza and influenza-related pneumonia, and it is emphasized that taking pneumonia and influenza vaccine together is effective in reducing mortality as well as hospitalization rates and costs due to pneumonia, influenza, and congestive heart disease.

This study that will be carried out will enable to determine the population-based prevalence of the relevant vaccines in the elderly and to determine the determinants of vaccination with the case group to be determined based on this.

The aim of the study is two phases.

1. Determination of the prevalence of seasonal influenza and pneumococcal vaccination in elderly people over the over the age of 65 living in Ankara. 2. Investigation of socioeconomic characteristics and vaccine indecision and some health-related determinants of vaccination through the case group created based on the preliminary study on the prevalence of seasonal influenza and pneumococcal vaccination in the elderly over the age of 65 living in Ankara.

The study, which includes cross-sectional prevalence and retrospective case-control stages, is planned to be carried out with individuals over the age of 65 living in Ankara province between November 1 and December 31, 2022.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Immunization; Infection Behavior Health Behavior Infections Influenza Influenza, Human Lung Diseases Orthomyxoviridae Infections Pneumonia RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Treatment Adherence and Compliance Treatment Refusal Vaccination Refusal Vaccine Refusal Virus Diseases

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Lokman Hekim University

Ankara, Çankaya, 06510, Turkey (Türkiye)

About this study

In recent years, progress has been made in vaccination as a result of the increase in health-seeking behavior due to the pandemic, the greater importance of influenza and pneumococcal vaccine application recommendations, and the perception of the prevention of lung infections due to COVID-19.

However, the discussions on the need to predict vaccine demand and examine health behaviors, health education, and research on new methods of vaccination efficacy in reducing future epidemics continue to be relevant.

Research questions-Prevalence

What is the prevalence of influenza vaccination in the elderly?
What is the prevalence of pneumonia vaccination in the elderly?

Research Questions - Case Control

Are socio-economic characteristics (region of residence, monthly income, education, perceived economic status) effective in vaccinating the elderly?
Are health-related features (chronic illness, drug use, previous vaccination status, priority preference in health care, frequency of hospitalization and hospitalization in the last six months, distance from health institution, self-defense behavior) effective in vaccinating the elderly?
Is the vaccination attitude effective in vaccinating the elderly?

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-Over the age of 65.

Exclusion criteria

Cancer diagnosis
Having a disease that will require immunosuppressive treatment
Transplantation cases
Rheumatoid arthritis
Systemic lupus erythematosus
Inflammatory bowel disease

Treatment and study plan

Primary outcomes

Number of Influenza Vaccination uptake

Time frame: During 2022

The number of self reported influenza vaccine uptake

Sponsors and collaborators

Lead sponsor

Lokman Hekim University

Other Gov

Registry information

Official study title

Prevalence of Seasonal Influenza and Pneumococcal Vaccination and Determinants of Vaccination in the Elderly: Nested Case-Control Study

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: Dec 22, 2022
Registry last updated: Feb 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting